Abstracts tagged "rheumatoid arthritis (RA) and socio-economic inequities"

Abstract Number: 117 • 2016 ACR/ARHP Annual Meeting
The Relationship Between Socioeconomic Factors and Dmards Use in Rheumatoid Arthritis
Adegbenga Bankole, Rheumatology, Carilion Clinic, Roanoke, VA
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder affecting millions of Americans with societal costs estimated in the billions. With the expansion in…
Abstract Number: 1252 • 2016 ACR/ARHP Annual Meeting
Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis
Rodolfo Perez-Alamino¹, Sharon Dowell², Gail S. Kerr³, Christopher Swearingen⁴, Yusuf Yazici⁵, Luis Espinoza⁶, Ignacio Garcia- Valladares⁷, Yvonne Sherrer⁸, Edward L. Treadwell⁹, Angelia Mosley-Williams¹⁰, Theresa Lawrence Ford¹¹, Akgun Ince¹², Mercedes Quinones², Jorge Flautero Arcos¹³ and Arielle Mcdonald¹⁴, ¹Rheumatology, Hospital Avellaneda, Tucuman, Argentina, Tucuman, Argentina, ²Howard University Hospital, Washington, DC, ³Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ⁴Pediatrics & Biostatistics, University of Arkansas, Little Rock, AR, ⁵Rheumatology, New York University Medical Center, La Jolla, CA, ⁶Medicine-Section of Rheumatology, LSU Medical Center, New Orleans, LA, ⁷CIB, Guadalajara, Mexico, ⁸Rheum/Immunology, Arthritis Center, Fort Lauderdale, FL, ⁹Dept Medicine Div of Rheum, E Carolina Univ Sch of Med, Greenville, NC, ¹⁰John Dingell VAMC, Detroit, MI, ¹¹North Georgia Rheumatology Group, PC, Lawrenceville, GA, ¹²Arthitis Consultants Inc, Saint Louis University, St. Louis, MO, ¹³Rheumatology, Howard University Hospital, Washington, DC, ¹⁴Howard University, Washington, DC, DC
Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis Background/Purpose: Ethnic disparities in outcomes of RA patients have been…
Abstract Number: 2051 • 2014 ACR/ARHP Annual Meeting
Modification of Effects of Household Income and Homeownership By Block Group Poverty on Health Outcomes in a Cohort of African Americans with Rheumatoid Arthritis
Rebecca J. Cleveland¹, Jennifer Smith², Antoine A. Baldassari¹, Beth L. Jonas³, Doyt L. Conn⁴, Larry W. Moreland⁵, S. Louis Bridges Jr.⁶ and Leigh F. Callahan⁷, ¹Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Heritage College of Medicine, Ohio University, Athens, OH, ³Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Rheumatology, Emory Univ School of Medicine, Atlanta, GA, ⁵University of Pittsburgh, Pittsburgh, PA, ⁶University of Alabama at Birmingham, Birmingham, AL, ⁷Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC
Background/Purpose We previously found that household income less than $30k/yr and not owning a home influenced rheumatoid arthritis (RA) disease severity measures. We sought to…
Abstract Number: 1373 • 2014 ACR/ARHP Annual Meeting
Physical Function of Patients with RA Varies Importantly Across Countries, and These Differences Are Not Attributed to GDP: Results from Multi-National Study with 17 Countries
Polina Putrik¹, Sofia Ramiro², Andras Keszei³, Ihsane Hmamouchi⁴, Maxime Dougados⁵, Till Uhlig⁶, Tore K. Kvien⁶ and Annelies Boonen⁷, ¹Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam & Hospital Garcia de Orta, Almada, Portugal, Amsterdam, Netherlands, ³Medical Informatics, Uniklinik RWTH Aachen University, Aachen, Germany, ⁴Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, ⁵Cochin Hospital, Paris Descartes University, Paris, France, ⁶Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁷Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose Physical function is an important outcome in RA and is essential for patients' quality of life. Is has not yet been sufficiently explored whether…
Abstract Number: 1164 • 2014 ACR/ARHP Annual Meeting
Inequity: Level of Education Is Associated with Access to Biologic Dmards Even in a Country with Highly Developed Social Welfare (Norway)
Polina Putrik¹, Sofia Ramiro², Elisabeth Lie³, Andras Keszei⁴, Desirée van der Heijde⁵, Robert Landewé⁶, Tore K. Kvien⁷, Till Uhlig⁷ and Annelies Boonen⁸, ¹Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam & Hospital Garcia de Orta, Almada, Portugal, Amsterdam, Netherlands, ³Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Medical Informatics, Uniklinik RWTH Aachen University, Aachen, Germany, ⁵Leiden University Medical Center, Leiden, Netherlands, ⁶Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, ⁷Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁸Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose Biologic DMARDs (bDMARDs) have greatly improved the outcome of rheumatoid arthritis (RA). Investigating possible inequities in access to bDMARDs across socio-economic factors is important,…
Abstract Number: 1153 • 2014 ACR/ARHP Annual Meeting
Area of Residence and Socio-Economic Factors Significantly Affect Access to Biological Therapy for Rheumatoid Arthritis Patients in Romania
Catalin Codreanu¹, Corina Mogosan², Ruxandra Ionescu³, Ioan Ancuta⁴, Magda Parvu⁵ and Simona Rednic⁶, ¹5 Thomas Masaryk Street, 'Dr. Ion Stoia' Clinical Center of Rheumatic Diseases, Bucharest, Romania, ²'Dr. Ion Stoia' Clinical Center of Rheumatic Diseases, Bucharest, Romania, ³Rheumatology, Sfanta Maria Clinical Hospital, UMF Carol Davila, Bucharest, Romania, ⁴“Dr. I. Cantacuzino” Hospital, Bucharest, Romania, ⁵Rheumatology, Colentina Clinical Hospital, Bucuresti, Romania, ⁶Rheumatology, University of Medicine and Pharmacy, Cluj-Napoca, Romania
Background/Purpose Clinical trials have proven the efficacy of biological therapy for rheumatoid arthritis (RA) worldwide. However, high costs have set boundaries to their use, especially…
Abstract Number: 1059 • 2014 ACR/ARHP Annual Meeting
Patients with RA from Wealthier Countries Perform Better on Clinical Disease Activity Measures, but Tend to Show Worse Person Reported Outcomes
Polina Putrik¹, Sofia Ramiro², Andras Keszei³, Ihsane Hmamouchi⁴, Maxime Dougados⁵, Monika Hifinger⁶, Laure Gossec⁷ and Annelies Boonen⁸, ¹Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam & Hospital Garcia de Orta, Almada, Portugal, Amsterdam, Netherlands, ³Medical Informatics, Uniklinik RWTH Aachen University, Aachen, Germany, ⁴Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, ⁵Cochin Hospital, Paris Descartes University, Paris, France, ⁶Rheumatology, MUMC, University Hospital Maastricht, Maastricht, Netherlands, ⁷Rheumatology, Pierre et Marie Curie University, Paris, France, ⁸Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose Inequalities in health between low and high income countries are often reported, but it is not known whether clinical disease activity measures (“objective”) and…
Abstract Number: 101 • 2014 ACR/ARHP Annual Meeting
Country of Residence and Its Wealth Determine Disease Activity Levels in RA: Results from Multi-National Study Across 17 Countries (COMORA)
Polina Putrik^1,2, Sofia Ramiro³, Andras Keszei⁴, Ihsane Hmamouchi⁵, Maxime Dougados⁶, Till Uhlig⁷, Tore K. Kvien⁷ and Annelies Boonen⁸, ¹Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²Health Promotion, Maastricht University, Maastricht, Netherlands, ³Rheumatology, Amsterdam Rheumatology Center, University of Amsterdam & Hospital Garcia de Orta, Almada, Portugal, Amsterdam, Netherlands, ⁴Medical Informatics, Uniklinik RWTH Aachen University, Aachen, Germany, ⁵Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, ⁶Cochin Hospital, Paris Descartes University, Paris, France, ⁷Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁸Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose Socio-economic (SE) inequalities in health persist both between and within countries and even increased in the recent years. Therefore, it is important to explore…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].